QUANTI CNS : Efficacy and Safety of Gadoquatrane in Patients Undergoing Contrast-Enhanced MRI of the Central Nervous System at Reduced Gadolinium Dose[大会長賞記録]
Japanese Journal of Magnetic Resonance in Medicine · 15.02.2026 · 46 (1) · 27-28
DOI: 10.2463/jjmrm.2025-1865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Magnetic Resonance in Medicine, erschienen am 15.02.2026. Verfasst von 與亮 工藤.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
工藤, 與. (2026). QUANTI CNS : Efficacy and Safety of Gadoquatrane in Patients Undergoing Contrast-Enhanced MRI of the Central Nervous System at Reduced Gadolinium Dose[大会長賞記録]. Japanese Journal of Magnetic Resonance in Medicine, 46(1), 27-28. https://doi.org/10.2463/jjmrm.2025-1865
Vancouver
工藤 與. QUANTI CNS : Efficacy and Safety of Gadoquatrane in Patients Undergoing Contrast-Enhanced MRI of the Central Nervous System at Reduced Gadolinium Dose[大会長賞記録]. Japanese Journal of Magnetic Resonance in Medicine. 2026;46(1):27-28. doi:10.2463/jjmrm.2025-1865
BibTeX
@article{2026,
author = {工藤, 與亮},
title = {QUANTI CNS : Efficacy and Safety of Gadoquatrane in Patients Undergoing Contrast-Enhanced MRI of the Central Nervous System at Reduced Gadolinium Dose[大会長賞記録]},
journal = {Japanese Journal of Magnetic Resonance in Medicine},
year = {2026},
volume = {46},
number = {1},
pages = {27--28},
doi = {10.2463/jjmrm.2025-1865}
}
EUVIMED